Leading the Way in Life Science Technologies

GEN Exclusives

More »
GEN Articles

Related to FDA Filing for Tarsa’s Oral Calcitonin Projected by Year-End Following Positive Phase III Data

  • Page 2 of 2 (25 items) First 1 2 

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »